- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3986
10-year publication summary
|
223
|
298
|
267
|
270
|
296
|
306
|
324
|
380
|
344
|
226
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deciphera Pharmaceuticals, LLC | 267 |
73 |
| Novartis AG | 10173 |
58 |
| Incyte Corporation | 1066 |
49 |
| F. Hoffmann-La Roche AG | 7808 |
47 |
| Immunomedics, Inc. | 239 |
44 |
| Merck Sharp & Dohme LLC | 3737 |
44 |
| Bristol-myers Squibb Company | 4757 |
43 |
| Merck Patent GmbH | 5735 |
38 |
| Hoffmann-La Roche Inc. | 3818 |
37 |
| Bayer Pharma AG | 1009 |
35 |
| Boehringer Ingelheim International GmbH | 4486 |
34 |
| Gilead Sciences, Inc. | 2236 |
33 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 69 |
32 |
| Bayer AG | 3522 |
31 |
| Pfizer Inc. | 3409 |
27 |
| Takeda Pharmaceutical Company Limited | 2700 |
27 |
| Pliant Therapeutics, Inc. | 66 |
25 |
| Nanjing Nutrabuilding Bio-Tech Co., Ltd. | 273 |
24 |
| Neurocrine Biosciences, Inc. | 463 |
24 |
| Genentech, Inc. | 4114 |
23 |
| Other owners | 3238 |